Browse All

Current Filters

CLEAR FILTER x

TITLE

Focusing on Mithocondrial Dysfunction in Multiple Sclerosis: The Role of GDF-15 and FGF-21 as Prognostic Biomarkers

Diagnostic Biomarkers Prior to Immunosuppressive Treatments: Multiple Sclerosis Compared to Control Non-autoimmune and Autoimmune Patient Groups

Macrophage Galactose C-type Lectin Exacerbates MS Pathogenesis in EAE Murine Model

Reduced Cerebrospinal Fluid Biomarkers (Neurofilament Light Chain, B Cells, T Cells) and Improved Clinical/Imaging Assessments of Disease Activity Are Sustained After 5 Years of Ocrelizumab Treatment: Long-term Extension Results from OBOE